Endocrinology · 2003 · 116 citations · 29 references
Life SciencesNeurosciencePharmacologyMitochondrial BiologyNeurodegenerationNeuropharmacologyMitochondrial Function In NeuronsMitochondrial MetabolismMitochondrial PhysiologyNeurodegenerative DiseasesParkinson DiseaseParkinsonian DisordersDopaminergic NeurodegenerationDopaminergic Neuron DeathDopaminergic NeuroprotectionNigrostriatal Dopamine SystemOxidative Stress InjuryParkinsonian DegenerationSubstantia Nigra PhysiologyUncoupling Proteins
Parkinson's disease is characterized by dopamine cell loss of the substantia nigra. Parkinson's disease and the neurotoxin 1-methyl-4-phenyl-1,2,5,6 tetrahydropyridine may destroy dopamine neurons through oxidative stress. Coenzyme Q is a cofactor of mitochondrial uncoupling proteins that enhances state-4 respiration and eliminate superoxides. Here we report that short-term oral administration of coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss after 1-methyl-4-phenyl-1,2,5,6 tetrahydropyridine administration in monkeys.
29
Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia
Christophe Fleury, Maria Neverova, Sheila Collins et al. · Nature Genetics · 1997 · 1.6K citations
Medicine, Endocrinology, Genetics +12
Superoxide activates mitochondrial uncoupling proteins
Karim S. Echtay, Damien Roussel, Julie St‐Pierre et al. · Nature · 2002 · 1.4K citations
Effects of Coenzyme Q10 in Early Parkinson Disease
Clifford W. Shults · Archives of Neurology · 2002 · 977 citations